Trial intelligence / Profile preview

Diaphragm and intercostal EMG before and after salbutamol in acutely dyspneic children

NL-OMON40181Active, not recruiting

Sponsor
University Medical Center Groningen
Start
Feb 2014
Modality
Small Molecules
Countries
1
01

Overview

Open-label trial of salbutamol (2 arms), sponsored by University Medical Center Groningen. Primary endpoint: Change in EMG values before and after salbutamol. Started Feb 2014; status: active, not recruiting.

02

Drugs

salbutamol

Beyond the preview

Go deeper on NL-OMON40181.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NL-OMON40181.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call